Philadelphia, PA USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

Treatment Combination to Improve Survival in HER2-Negative Metastatic Breast Cancer

The study, “A Real-World Multicentre Retrospective Observational Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line Treatment for HER2-Negative Metastatic Breast Cancer,” was recently published in the Journal of Cell...
30-Nov-2016 1:05 PM EST Add to Favorites

New Study ‘Sheds Light’ on the Mechanisms Safeguarding the Genome

Understanding the molecular mechanisms that exist for cells to safeguard their genome against cancer-causing defects is crucial not only to understand how cancer arises but also because these mechanisms can be targeted therapeutically. Researchers...
31-Oct-2016 9:00 AM EDT Add to Favorites

Researchers Slow Glioblastoma by Inhibiting Tumor’s PPARα Receptor

One of the most remarkable features of glioblastoma is the metabolic reprogramming of cancerous cells, resulting in uncontrolled cell proliferation, hypoxic conditions and angiogenesis. Metabolic reprogramming enables tumor cells with a faster way...
26-Oct-2016 1:05 PM EDT Add to Favorites

Women Leaders in Advanced Cancer Research

The Sbarro Health Research Organization (SHRO), in collaboration with Temple University’s College of Science and Technology, the National Italian American Foundation (NIAF), and the Giovan Giacomo Giordano Foundation will host the medical...
12-Oct-2016 1:05 PM EDT Add to Favorites

New RNA Stem Cell Editing Reduces Unintended Genetic Complications

An international collaboration of government, university, and industry resources showed the promise of using RNA as a safe way to both make and modify induced Pluripotent Stem Cells (iPSCs) from patient cells for clinical applications in...
3-Oct-2016 2:05 PM EDT Add to Favorites

The Complex Crosstalk Between Obesity and Breast Cancer

SbarroResearch.article567092.jpg

A new study published in the Journal of Cell Physiology describes how inflammation that characterizes fatty tissue is one of the main microenvironment actors responsible for promoting cancer. The authors also describe the involvement of steroid...
20-Jul-2016 9:40 AM EDT Add to Favorites

Concurrent Administration of Antrhacyclines and Trastuzumab in Breast Cancer Patients: New Findings for an Old Challenge

USA-ITALY May 2016. The study entitled “A phase II neoadjuvant sequential regimen of docetaxel followed by high-dose epirubicin in combination with cyclophosphamide administered concurrently with trastuzumab. The DECT trial” has recently...
20-May-2016 2:05 PM EDT Add to Favorites

Old Drug Could Fight Brain Cancer by Starving It to Death

Glioblastoma, the most common form of brain cancer is a deadly disease for which at present there is no cure. Now, researchers have published research results that show how repurposing the old drug flavopiridol could be an effective strategy to cut...
18-May-2016 8:05 AM EDT Add to Favorites

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.




Chat now!